| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| IUPHAR/BPS | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C15H24N4S |
| Molar mass | 292.45 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Thioperamide is apotentHRH4 antagonist andselectiveHRH3antagonist capable of crossing theblood–brain barrier.[1]It was used byJean-Charles Schwartz in his early experiments regarding the H3 receptor.[2] Thioperamide was found to be an antagonist of histamineautoreceptors, which negatively regulate the release of histamine. The drug enhances the activity of histaminergic neurons by blocking autoreceptors, leading to greater release of histamine.
Its action on H3 receptors is thought to promote wakefulness and improve memory consolidation.
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |